Novo Nordisk A/S
NVO
$47.26
$1.292.81%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 17.99B | 18.81B | 15.45B | 15.30B | 16.18B |
| Total Depreciation and Amortization | 2.08B | 2.10B | 2.09B | 1.90B | 1.69B |
| Total Amortization of Deferred Charges | 49.57M | 49.57M | 49.57M | 36.44M | 36.44M |
| Total Other Non-Cash Items | 1.09B | -999.87M | -768.29M | 1.39B | 829.40M |
| Change in Net Operating Assets | -670.16M | -1.50B | 1.43B | 200.70M | -682.03M |
| Cash from Operations | 20.54B | 18.46B | 18.25B | 18.82B | 18.06B |
| Capital Expenditure | -8.68B | -8.97B | -9.13B | -8.56B | -8.21B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -142.90K | 4.50K |
| Cash Acquisitions | 156.49M | 156.49M | 156.49M | -11.65B | -11.65B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.31B | -4.22B | -3.11B | 1.76B | 749.77M |
| Cash from Investing | -12.84B | -13.04B | -12.08B | -18.44B | -19.11B |
| Total Debt Issued | 66.08B | 92.55B | 103.93B | 118.07B | 117.48B |
| Total Debt Repaid | -29.64B | -68.39B | -79.19B | -78.47B | -77.85B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -5.90B | -2.40B | -1.39B | -8.88B | -11.28B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.03B | -8.03B | -7.59B | -7.59B | -7.27B |
| Other Financing Activities | -2.76B | -22.37B | -1.95B | -1.95B | -1.95B |
| Cash from Financing | -3.68B | -7.96B | -4.64B | -3.96B | -4.00B |
| Foreign Exchange rate Adjustments | -8.05M | -139.20M | -108.95M | -23.01M | -84.15M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.01B | -2.68B | 1.43B | -3.61B | -5.13B |